Samara Capital
General
Grapevine: Oyo, Samara-backed Marengo eye funding; Table Space weighs IPO
Oravel Stays, the parent company of SoftBank-backed Oyo, is in preliminary talks to secure $200 million (about Rs 1,680 crore) ......
General
Deals Digest: Fundraising drops to the lowest in six weeks on high base
Funding momentum in the startup ecosystem this week declined to a six-week low on a high base during the preceding week, ......
Finance
Creador, Norwest join Samara Capital for India PE buyout as deal value climbs
India- and Southeast Asia-focused private equity firm Creador as well as venture capital and growth equity investment firm Norwest Venture ......
General
Grapevine: PEs eye India's largest cardiac stent maker; O2 Power race heats up
Private equity firms KKR, TPG Capital and Apax Partners are evaluating India's largest cardiac stent maker Sahajanand Medical Technologies (SMT), valuing the company at ......
General
Grapevine: Samara in talks to buy Bharti's Del Monte stake; Healthium gets another suitor
Private equity firm Samara Capital is in advanced discussions to acquire a 50% stake in Del Monte Foods, a pasta ......
General
Grapevine: Samara struggles to sell More Retail stake; Morgan Stanley PE mulls an exit
Private equity firm Samara Capital has received a tepid response so far for a 20% stake sale in More Retail with potential ......
General
Grapevine: EQT, Temasek plan O2 Power exit; Samara, Convergent to form $150 mn food venture
Global investment giants EQT Capital and Temasek have planned to divest their renewable energy platform, O2 Power, aiming to capitalize ......
General
Deals Digest: Big-ticket M&As, growth-stage bets dominate dealmaking
Private equity and venture capital deal flow saw a substantial jump in the week through Friday, both in terms of value ......
Healthcare
Samara Capital in talks to invest in botanical ingredients maker
Homegrown private equity fund Samara Capital is in advanced stages of talks to invest in a natural ingredients supplier that ......
Healthcare
Samara Capital in fray to invest in PE-backed contract drugmaker
Homegrown private equity firm Samara Capital has emerged as one of the frontrunners to invest in a Mumbai-based pharmaceutical development ......